Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)

Clinical trial NCT01473264 · COMPLETED

Trial details

NCT number: NCT01473264
Sponsor: Clarassance, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Respiratory Distress Syndrome in Premature Infant Bronchopulmonary Dysplasia

Start date: 2000-01-01
Primary completion: 2002-06-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.